Tech Company Financing Transactions
Theravent Funding Round
Theravent, based in Mancheste, scored $16.3 million from De Novo Ventures and private investors.
Transaction Overview
Company Name
Announced On
3/31/2008
Transaction Type
Venture Equity
Amount
$16,250,000
Round
Undisclosed
Investors
De Novo Ventures (David Mauney)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
373 South Willow St. 306
Mancheste, NH 03103
USA
Mancheste, NH 03103
USA
Phone
Website
Email Address
Overview
Theravent is a private medical device company that is dedicated to changing the lives of people with sleep-disordered breathing. Theravent has developed a new breakthrough therapy for obstructive sleep apnea (OSA).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Wyles
Chief Medical Officer
Philip Westbrook
VP - R & D
Mike Favet
Browse more venture capital transactions:
Prev: 3/31/2008: mindSHIFT Technologies venture capital transaction
Next: 3/31/2008: Control4 venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs